157 related articles for article (PubMed ID: 22691110)
21. Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler.
Mehta R; Daley-Yates PT; Jenkins K; Bianco J; Stylianou A; Louey MD; Chan RH
Pulm Pharmacol Ther; 2014 Oct; 29(1):66-73. PubMed ID: 25035069
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease.
Leaker BR; Singh D; Nicholson GC; Hezelova B; Goodin T; Ozol-Godfrey A; Galluppi G; Barnes PJ
Respir Res; 2019 Jun; 20(1):132. PubMed ID: 31253162
[TBL] [Abstract][Full Text] [Related]
23. Dose emission characteristics of placebo PulmoSphere® particles are unaffected by a subject's inhalation maneuver.
Weers J; Ung K; Le J; Rao N; Ament B; Axford G; Maltz D; Chan L
J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):56-68. PubMed ID: 22691109
[TBL] [Abstract][Full Text] [Related]
24. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
Yildiz P; Bayraktaroglu M; Gorgun D; Yuksel K
Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler.
Mehta R; Riddell K; Gupta A; Louey MD; Chan RH
Clin Drug Investig; 2015 May; 35(5):319-26. PubMed ID: 25805608
[TBL] [Abstract][Full Text] [Related]
26. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.
Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Patzlaff A; Weimann B
J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):156-163. PubMed ID: 30848695
[No Abstract] [Full Text] [Related]
27. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
Daley-Yates PT; Richards DH
Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers.
Abbara C; Rousseau JM; Turcant A; Lallement G; Comets E; Bardot I; Clair P; Diquet B
Br J Pharmacol; 2009 Aug; 157(8):1390-7. PubMed ID: 19681868
[TBL] [Abstract][Full Text] [Related]
29. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats.
Khadka P; Sinha S; Tucker IG; Dummer J; Hill PC; Katare R; Das SC
Eur J Pharm Biopharm; 2021 May; 162():1-11. PubMed ID: 33639255
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
[TBL] [Abstract][Full Text] [Related]
32. Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects.
Wilson R; Jarvis E; Montembault M; Hamblin JN; Hessel EM; Cahn A
Clin Ther; 2018 Aug; 40(8):1410-1417. PubMed ID: 30055824
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices.
Seppälä OR; Aalto E; Annila ; Hakonen T; Lukkari-Lax E; Jouhikainen T; Nieminen MM; Liipp K
Respir Med; 2001 Dec; 95(12):949-53. PubMed ID: 11778791
[TBL] [Abstract][Full Text] [Related]
34. Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder.
Obaidi M; Offman E; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2013 Sep; 53(8):1323-33. PubMed ID: 23992438
[TBL] [Abstract][Full Text] [Related]
35. Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids.
Kerwin EM; Gillespie M; Song S; Steinfeld J
J Asthma; 2017 Jan; 54(1):89-98. PubMed ID: 27285965
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector.
Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA
Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684
[TBL] [Abstract][Full Text] [Related]
37. Comparison of intravenous and endobronchial atropine: a pharmacokinetic and -dynamic study in pigs.
Hörnchen U; Schüttler J; Stoeckel H; Ensing K; de Zeeuw RA; Eichelkraut W
Eur J Anaesthesiol; 1989 Mar; 6(2):95-101. PubMed ID: 2721508
[TBL] [Abstract][Full Text] [Related]
38. Inhaled PYY(3-36) dry-powder formulation for appetite suppression.
Kuehl PJ; Boyden T; Dobry DE; Doyle-Eisele M; Friesen DT; McDonald JD; Murri BG; Vodak DT; Lyon DK
Drug Dev Ind Pharm; 2016 Jan; 42(1):150-156. PubMed ID: 26006332
[TBL] [Abstract][Full Text] [Related]
39. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
Mahler DA; Waterman LA; Ward J; Gifford AH
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
[TBL] [Abstract][Full Text] [Related]
40. Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers.
Persson G; Ankerst J; Gillen M; Bengtsson T; Thorsson L
Curr Med Res Opin; 2008 May; 24(5):1511-7. PubMed ID: 18419877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
